Business
DarioHealth to be Added to Russell 2000® and 3000® Indexes
NEW YORK, June 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to
About this update from Dariohealth Corp.
[{"type":"text","content":"NEW YORK, June 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to join the broad-market Russell 3000® Index and the small-cap Russell 2000® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective after the US equity markets open on Monday, June 28, 2021, according to a preliminary list of additions posted by FTSE Russell on Friday, June 4, 2021.\nAnnual reconstitution of the Russell indexes captures the 4,000 largest U.S. stocks as of May 7, 2021, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.\n\"Inclusion in the Russell indexes reflects the hard work and achievements of the entire Dario team as we work to build the premier digital health and therapeutics company,\" stated Erez Raphael, Chief Executive Officer of DarioHealth. \"We look forward to a heightened awareness of our company that inclusion in these widely-followed indexes confers.\" \nRussell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell's US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.\nFor more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the \"Russell Reconstitution\" section on the FTSE Russell website: https://www.ftserussell.com/resources/russell-reconstitution\nAbout DarioHealth Corp.\nDarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario's next-generation, AI-powered, digital therapeutic solutions support more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help ...